Definitive Healthcare publishes 2023 Sustainability Report
Definitive Healthcare (Nasdaq: DH) today released its 2023 sustainability report.
Definitive Healthcare appoints Kevin Coop as CEO for next phase of company’s growth
Definitive Healthcare today announced that its Board of Directors has appointed Kevin Coop as the Company’s next Chief Executive Officer and as a…
Definitive Healthcare reports financial results for first quarter fiscal year 2024
Definitive Healthcare (Nasdaq: DH), announces financial results for the quarter ended March 31, 2024.
Definitive Healthcare announces timing of its first quarter 2024 financial results conference call and webcast
Definitive Healthcare (Nasdaq: DH) will report its first-quarter financial results on Tuesday, May 7, 2024 at 5:00 p.m. ET.
Definitive Healthcare introduces Carevoyance sales enablement solution for medtech industry
Definitive Healthcare announced the launch of Carevoyance, an innovative sales enablement solution tailored for medtech organizations.
VML and Definitive Healthcare announce partnership to transform key opinion leader management
Definitive Healthcare (Nasdaq: DH) and VML Health announced a first-of-its-kind partnership that gives clients the ability to manage their entire key…
Definitive Healthcare earns 2024 Middle Market Leader Award from Boston Business Journal
Definitive Healthcare has been named one of the Boston Business Journal’s Middle Market Leaders for 2024, a ranking of the 50 highest growth companies…
Definitive Healthcare reports financial results for fourth quarter and full fiscal year 2023
Definitive Healthcare (Nasdaq: DH) announces financial results for the fourth quarter and the full year that ended December 31, 2023.